CEACAM5 | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Conferences Trial results

10 September 2024

World Lung 2024 – a way forward for CEACAM5?

Patients' expression of CEACAM5 might hold the key to activity after all.

Trial results

21 December 2023

Sanofi switches to another CEACAM5 asset

Subscribe to CEACAM5